Does the type of prosthesis influence the incidence of permanent pacemaker implantation following isolated aortic valve replacement?

Heart Surgery Forum

Volumn 8, Issue 6, 2005, Pages 373-377

  Elahi, Maqsood M ^a   Osman, Khalid A ^a   Bhandari, Manoj ^a   Dhannapuneni, Ramana Rao V ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AORTA VALVE PROSTHESIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; FEMALE; HEART LEFT BUNDLE BRANCH BLOCK; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERIOPERATIVE PERIOD; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; STENT; SURGICAL APPROACH; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; AGED; AORTA VALVE STENOSIS; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART ARRHYTHMIA; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; METHODOLOGY; MIDDLE AGED; STATISTICS; UNITED KINGDOM;

ADULT; AGED; AORTIC VALVE STENOSIS; ARRHYTHMIA; COMORBIDITY; FEMALE; GREAT BRITAIN; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 34247203135     PISSN: 10983511     EISSN: None     Source Type: Journal    
DOI: 10.1532/HSF98.20051025     Document Type: Article

References (19)

1. Blais C, Dumesnil JG, Baillot R, Simard S, Doyle D, Pibarot P. 2003. Impact of valve prosthesis-patient mismatch on short term mortality after aortic valve replacement. Circulation 108:983-8.
2. Boughaleb D, Mansourati J, Genet L, Barra J, Mondine P, Blanc JJ. 1994. Permanent cardiac stimulation after aortic valve replacement: incidence, predictive factors and long-term prognosis. Arch Mal Coeur Vaiss 87:925-30.
3. Braunwald E. 2000. Aortic valve replacement; an update at the turn of the millennium. Eur J Heart 21:1032-3.
4. Breisch EA, White FC, Bloor CM. 1984. Myocardial characteristics of pressure overload hypertrophy. A structural and functional study. Lab Invest 51:333-42.
5. Del Rizzo DF, Nishimura S, Lau C, Sever J, Goldman BS. 1996. Cardiac pacing following surgery for acquired heart disease. J Cardiovasc Surg 11:332-40.
6. Elahi MM, Lee D, Bhandari M, Dhannapuneni RV, Sosnowski AW. 2005. Permanent pacemaker implantation after valve surgery: assessing its need in early postoperative period: our experience in a tertiary centre. Br J Cardiol (in press).
7. Gerber IL, Stewart RA, Hammett CJ, et al. 2003. Effect of aortic valve replacement on C-reactive protein in nonrheumatic aortic stenosis. Am J Cardiol 92:1129-32.
8. Goldman BS, David TE, Del Rizzo DF, Sever J, Bos J. 1994. Stentless porcine bioprosthesis for aortic valve replacement. J Cardiovasc Surg 35:105-10.
9. Gordon RS, Ivanov J, Cohen G, Ralph-Edwards AL. 1998. Permanent cardiac pacing after a cardiac operation: predicting the use of permanent pacemakers. Ann Thorac Surg 66:1698-704.
10. Jalil JE, Doering CW, Janicki JS, et al. 1989. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 64:1041-50.
11. Keefe DL, Griffin JC, Harrison DC, Stinson EB. 1985. Atrioventricular conduction abnormalities in patients undergoing isolated aortic or mitral valve replacement. Pacing Clin Electrophysiol 8:393-8.
12. Kvidal P, Bergstorm R, Malm T, et al. 2000. Long term follow up of morbidity and mortality after aortic valve replacement with mechanical valve prostheses. Eur Heart J 21:1099-111.
13. Lewis JW Jr, Webb CR, Pickard SD, Lehman J, Jacobsen G. 1998. The increased need for a permanent pacemaker after reoperative cardiac surgery. J Thorac Cardiovasc Surg 116:74-81.
14. Limongelli G, Ducceschi V, D'Andrea A, et al. 2003. Risk factors for pacemaker implantation following aortic valve replacement: a single centre experience. Heart 89:901-4.
15. Morisco C, Sadoshima J, Trimarco B, Arora R, Vatner DE, Vatner SF. 2003. Is treating cardiac hypertrophy salutary or detrimental: the two faces of Janus. Am J Physiol Heart Circ Physiol 284:H1043-7.
16. Muiesan ML, Salvetti M, Rizoni D, Castellano M, Donato F, Agabiti-Rosei E. 1995. Association of change in left ventricular mass with prognosis during long-term anti-hypertensive treatment. J Hypertens 13:1091-5.
17. Pfeiffer MA, Braunwald E. 1990. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81:1161-72.
18. Sia YT, Lapointe N, Parker TG, et al. 2002. Beneficial effects of long-term use of the antioxidant probucol in heart failure in rat. Circulation 105:2549-55.
19. Verdecchia P, Schillaci C, Borgoni C, et al. 1998. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 273:2161-8.